• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI

ALGORAE PHARMACEUTICALS LIMITED - Charts / Financials

16.7% ! 0.5¢
Market Cap $8.436M  !
Healthcare Biotechnology
Add to My Watchlist

Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI)... Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI) enabled drug discovery and development company. The Company is actively engaged in expanding its therapeutic pipeline using a proprietary artificial intelligence (AI) drug discovery and development platform, known as Algorae Operating System (AlgoraeOS). The AI platform leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. By employing machine learning, deep learning, and neural networks, the AlgoraeOS is focused on uncovering synergistic fixed dose drug combinations that lead to the development of effective treatments for any medical condition. It is also focused on advancing its drug candidates, which include AI-116 for the treatment of neurodegenerative disorders and/or dementia, and AI-168 for cardiovascular disease and NTCELL for Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 29/07/2025 (20 minute delay) ?
Day
Open 0.6¢   Day High 0.6¢   Day Low 0.5¢
Daily Volume 2991398
Bids   Sellers
Number Price Volume   Number Price Volume
3 0.5¢ 1439794   5 0.6¢ 1531428

Directors & Senior Management

Mr. David Richard Hainsworth Executive Chairman of the Board
Mr. Daya Uka Chief Financial Officer
Dr. Belinda Di Bartolo Chief Operating Officer
Dr. James A. Mckenna Chief Scientific Officer
Mr. Vishal Shah Chief Commercial Officer
Dr. Carolyn M. Sue Chief Medical Officer
Ms. Jennifer Voon Company Secretary
Mr. Bradley John Dilkes Director
Mr. Bradley Roland Latham Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.5¢ 		Change
-0.001(16.7%) 		Mkt cap ! $8.436M
Open High Low Value Volume
0.6¢ 0.6¢ 0.5¢ $14.98K 2.991M

Buyers (Bids)

No. Vol. Price($)
3 1439794 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 1531428 5
View Market Depth
Last trade - 15.59pm 29/07/2025 (20 minute delay) ?
Last
0.5¢ 		  Change
-0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 987311
Last updated 15.59pm 29/07/2025 ?

Top Stories

ASX Market Close: Index treads water as Energy stocks lead

The ASX200 was trading flat late in Tuesday afternoon’s session.Utilities and Energy were the best performing sectors intraday, both in the green heading into market close. Financials was the biggest loser intraday, followed by Staples and Telecommunication.In the GreenStar Entert...
Wildcat’s PFS elicits lacklustre response Wildcat has issued a PFS for its Tabba Tabba project, but the market hasn’t liked it @ shares were down -8.3% at lunchtime. Some HotCopper users were concerned Wildcat has relied on assumed lithium prices well above what other majors like Pilbara Minerals (ASX:PLS) are currently s...
HotCopper Trends: Vection's $7M, Liontown dips & Wildcat PFS Let’s check in on what’s trending on the HotCopper forums on Tuesday. The following companies are catching eyes in the intraday session: Vection Technologies (ASX:VR1) @ Vection has received a contract extension from an undisclosed EU-based client worth just ove...
One of the biggest jumps today is the most obscure: Beonic Ltd up +65% The HotCopper forums collectively missed one of the day’s top gainers, as far as the list of most popular companies according to users goes. Beonic Ltd (ASX:BEO), an aviation-facing tech stock, has inked a deal to provide LIDAR-based passenger foot traffic data to seven airports i...
Emyria Advances kicks off National Rollout with Avive Health Agreement Clinical-stage biotech and mental health innovator Emyria Limited (ASX:EMD) has fired up its national expansion strategy by signing a landmark agreement with Avive Health, a growing private hospital operator, to establish its first Empax clinic in Queensland.Under the agreement, Emyria will integ...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.